AR103086A1 - Composiciones y métodos para reducir las infecciones en aves de corral - Google Patents

Composiciones y métodos para reducir las infecciones en aves de corral

Info

Publication number
AR103086A1
AR103086A1 ARP150104160A ARP150104160A AR103086A1 AR 103086 A1 AR103086 A1 AR 103086A1 AR P150104160 A ARP150104160 A AR P150104160A AR P150104160 A ARP150104160 A AR P150104160A AR 103086 A1 AR103086 A1 AR 103086A1
Authority
AR
Argentina
Prior art keywords
compositions
methods
composition
reduce infections
lactic acid
Prior art date
Application number
ARP150104160A
Other languages
English (en)
Inventor
P Lerner Steven
Original Assignee
Nutrition Physiology Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition Physiology Company Llc filed Critical Nutrition Physiology Company Llc
Publication of AR103086A1 publication Critical patent/AR103086A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicación 1: Una composición para reducir las infecciones por patógenos en un ave, caracterizada porque dicha composición comprende una cantidad eficaz de una bacteria productora de ácido láctico, donde dicha cantidad eficaz es una cantidad de dicha bacteria productora de ácido láctico que es capaz de reducir la coccidiosis en dicha ave. Reivindicación 7: La composición de cualquiera de las reivindicaciones 1 - 6, caracterizada porque dicha bacteria productora de ácido láctico es una cepa que se selecciona entre el grupo que consiste en las cepas LA51, LA45, NP28, y L411. Reivindicación 8: La composición de cualquiera de las reivindicaciones 1 - 7, caracterizada porque además comprende una vacuna contra la coccidiosis.
ARP150104160A 2014-12-17 2015-12-17 Composiciones y métodos para reducir las infecciones en aves de corral AR103086A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462093149P 2014-12-17 2014-12-17

Publications (1)

Publication Number Publication Date
AR103086A1 true AR103086A1 (es) 2017-04-12

Family

ID=56127599

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150104160A AR103086A1 (es) 2014-12-17 2015-12-17 Composiciones y métodos para reducir las infecciones en aves de corral

Country Status (3)

Country Link
US (1) US20160175369A1 (es)
AR (1) AR103086A1 (es)
WO (1) WO2016100674A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2689701C1 (ru) * 2018-07-12 2019-05-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" Способ выращивания перепелов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
WO2013071298A1 (en) * 2011-11-11 2013-05-16 Nutrition Physiology Company, Llc Lactic acid bacteria and their use as dietary supplementals for poultry
WO2014022572A1 (en) * 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction

Also Published As

Publication number Publication date
WO2016100674A1 (en) 2016-06-23
US20160175369A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
AR110684A1 (es) Composiciones que comprenden cepas bacterianas y método de tratamiento
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
PH12016501577A1 (en) Monobactam organic compounds for the treatment of bacterial infections
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
CL2017003151A1 (es) Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas
SV2017005462A (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
MX2016009898A (es) Tratamientos para acne resistente.
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
ECSP20084373A (es) Tiofencarboxamidas sustituidas y análogos de las mismas
CR20160433A (es) Nuevos compuestos
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
BR112016012599A2 (pt) composição, e, método para tratamento ou prevenção de uma infecção por staphylococcus aureus
MX2016013256A (es) Compuestos antibacterianos.
PE20141452A1 (es) Cepas de salmonella gallinarum modificadas avirulentas y composiciones farmaceuticas que las usan
PE20180036A1 (es) Inhibidores de bromodominio
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
MX2016012915A (es) Profarmacos de inhibidores de la transcriptasa inversa del virus de la inmunodeficiencia humana (vih).
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2017001329A1 (es) Conjunto bacteriano sinergístico destinado a movilizar el fósforo del suelo.
CL2016000672A1 (es) Bacteria aislada del género streptomyces
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
CL2017001818A1 (es) Bacteria de ácido láctico y su uso para el tratamiento de mastitis
CO2017010271A2 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
CL2020000859A1 (es) Derivados de ácido glucónico para ser usados en el tratamiento y/o prevención de infecciones microbianas.
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo

Legal Events

Date Code Title Description
FB Suspension of granting procedure